Sexual Dysfunction & Intimacy Concerns
Sexual Dysfunctions (DSM-5-TR)
Difficulties with sexual desire, arousal, orgasm, pain during sex, or overall sexual satisfaction that cause personal distress or interpersonal difficulty. Includes desire discrepancy, erectile dysfunction, anorgasmia, vaginismus/genito-pelvic pain, and intimacy avoidance. Often intertwined with relational dynamics, body image, trauma history, medical factors, and cultural/religious messaging about sexuality.
Prevalence: ~30-40% of adults report some form of sexual difficulty; prevalence varies by specific condition, age, and gender
Clinical Picture
Sexual dysfunction and intimacy concerns span a wide range — from specific physiological issues (erectile dysfunction, vaginismus, anorgasmia) to desire discrepancy in couples, to the broader psychological and relational dimensions of sexual experience. Effective treatment often requires attention to multiple levels simultaneously: the physiological, the psychological (anxiety, body image, trauma history), the relational (communication, power dynamics, emotional safety), and the cultural (messages about sexuality, gender roles, religious frameworks). Many therapists are uncomfortable with explicit sexual content and avoid it even when it's clinically relevant.
Treatment Considerations
Sex therapy draws from behavioral (sensate focus, originally Masters and Johnson), cognitive (addressing performance anxiety and sexual schemas), and relational (improving communication and emotional intimacy) approaches. For sexual dysfunction with trauma history, trauma-processing often needs to precede or accompany sex-specific interventions. EFT and Gottman approaches address the relational dimension of sexual disconnection. For specific dysfunctions, medical evaluation should be part of the workup. Therapists treating sexual concerns need specialized training — general clinical training is insufficient.
6 Therapeutic Approaches
Sorted by evidence tier: guideline-recommended first, then RCT-supported, then emerging/limited evidence.
Related Clinical Vignettes
Sources & References
Prevalence data from NIMH, WHO, and DSM-5-TR field trial publications. Evidence tiers reflect guideline status (APA, NICE, VA/DoD, WHO) and meta-analytic findings as of early 2025. Individual modality citations are listed on each modality page. Full bibliography available on the Sources page.